Navigation Links
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
Date:12/15/2010

The Simbiontes ("Symbionts" in English) Project brought together children, their families, artists and scientists in a first of its kind fundraising project in Portugal. A true symbiosis was established between several groups in society, leading to this award for scientific research.

Miguel Godinho Ferreira, group leader at the Instituto Gulbenkian de Cincia, just outside Lisbon, is the first scientist to win the 10,000 euros Simbiontes Award, for his proposal to investigate the cellular changes that cause cancer in adults. Over 80% of cancers appear in adults over 50, making age one of the main risk factors for this disease. Miguel Godinho Ferreira's research promises crucial insights into understanding the causes of cancer, and, potentially, into developing approaches to fight the disease.

Miguel's research interests lie in understanding why the incidence of cancer increases with age. He believes he has a clue as to what may underlie this phenomenon: "Chromosome ends have on them protective structures, made up of DNA, called telomeres. As we age, telomeres become shorter, thus acting like molecular clocks that convey the age of a cell."

Telomeres undergo lifelong wear and tear because the enzyme that builds them is not active in human cells. Indeed, telomerase - as this enzyme is called - is active only in the embryo, and becomes inactive at birth. Miguel and his team are looking for the signals associated to telomerase in young cells, that are absent in old cells. They hope to harness these molecular signals to stop cancer developing in older cells. Says Miguel, "If we could manipulate telomerase so that old cells could be tricked into believing they are younger than they really are, it might just be possible to stop cancer from developing. In this project we will try to prove this hypothesis, using first a model organism (yeast), then extending our findings into human cells, and, potentially, paving the way for new therapies.

Miguel Godinho Ferreira's project was chosen amongst 26 proposals that were submitted to an international panel of cancer research experts. The award marks the endpoint of the first edition of the Simbiontes project, put in place by the Associao Viver a Cincia, in collaboration with the Portuguese Institute of Oncology in Lisbon and the arts school Ar.Co. The aim of the project is to raise funds for research, through the engagement of several groups in society. A series of art workshops were run with children at the Institute of Oncology, based on the book "A Menina do Mar" by Sophia de Mello Breyner. The children made several paintings and drawings, that were auctioned in 2009. Furthermore, an illustrated children's book, titled "Os Amigos da Menina do Mar", by Raquel Gaspar (a biologist) and ngelo Encarnao (an artist), was published. The funds raised from the auction of the paintings and drawings, the sales of the book and other activities make up the Simbiontes award.

Miguel adds, "It is an honour to receive the Simbiontes award, for it's spirit as the public's contribution to scientific research. The value of the award is a small contribution to the project, since scientific research is very expensive, but it will allow us to be bolder in our research".


'/>"/>

Contact: Ana Godinho
agodinho@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia
Source:Eurekalert  

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Mensa GLAAM Conference to Feature Christian Drapeau, Stem Cell Author and Scientist
5. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
6. Scientists find donut-shaped structure of enzyme involved in energy metabolism
7. Neuroscientists reveal new links that regulate brain electrical activity
8. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
9. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
10. Scientists Spot Genetic Fingerprints of Individual Cancers
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: